Tuftsin-derived anxiolytic peptide
et al., BPC-157 improves tendon healing and angiogenesis , Journal of Orthopaedic Research Seiwerth S
Oral semaglutide Oral semaglutide in doses up to 14 mg once daily gained approval as T2D treatment by the Food and Drug Administration (FDA) in September 2019 based on the results of the phase 3 trials of the PIONEER program (up to 1.4% HbA1c reduction and up to 4.4 kg WL in the global trials) and become the first approved oral GLP-1 RA [26]
Of the 70+ molecules that have been identified in LBs, -synuclein is the most prominent [4,20]
This limitation makes conventional vitamin C a poor candidate for therapeutic conditions that demand high absorption vitamin C for sustained or elevated plasma concentrations, such as immune modulation, oxidative stress recovery, and surgical healing
Glutathione deficiency can develop due to a combination of lifestyle factors, environmental exposures, health conditions, and even genetics